Advanced onboard automation for Atlas HD reactors

Syrris has upgraded the touchscreen firmware for its popular Atlas HD jacketed reactor systems to offer many of the advanced automation features previously only available using the system’s PC-based control software. These enhanced automation options – such as pH-controlled and temperature-dependent dosing – add to the system’s existing functionality to offer even greater flexibility in protocol design.

Pathology in Practice editor awarded IBMS Life Membership

Earlier this year, Pathology in Practice editor Brian Nation CSci FIBMS was awarded Institute of Biomedical Science (IBMS) Life Membership. The presentation was made by Institute President Alison Geddes at a ceremony held during the Biomedical Science Congress event in September.

New cell models now cover a wide range of diseases

PromoCell, a manufacturer of human primary cells and cell culture products, now offers cell disease models covering a wide range of diseases including diabetes (type 1 and 2), respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma, as well as cardiomyopathy. Relevant models enable experiments under physiological conditions and are key to developing new therapies for chronic diseases. With its greater range of cell disease models, PromoCell underlines its role as a dedicated supporter of scientific research and innovation.

Hub-and-spoke laboratory set-up on show

HORIBA UK, Medical showcased its approach to ‘hub and spoke’ laboratories at the IBMS Congress in September. On the stand was a wide range of instrumentation for central laboratory and near-patient use, and also a newly CE-marked benchtop instrument for rapid infectious disease detection.

Lab Innovations 2019 attracted record-breaking visitor numbers

Lab Innovations celebrated its eighth edition in October, trumping all records for the event. Attracting 3860 attendees, an impressive 24% increase on the previous year, this makes it the largest Lab Innovations to date. Over 160 exhibitors displayed a diverse and innovative product offering to visitors from more sectors than ever before, emphasising the event’s place as the UK’s largest annual trade exhibition dedicated to the entire laboratory industry.

Genomic and molecular revolution in microbiology: a BSMT meeting

The 35th British Society for Microbial Technology (BSMT) Annual Scientific Conference will be held on Thursday 14 May 2020 at the RAF Museum, Hendon, entitled The Genomic and Molecular Revolution in Microbiology: In Technology We Trust (or do we?). The theme of the meeting is designed to explore just how much the molecular revolution in microbiology has been useful in improving patient care, and the organisers have a great line up of speakers already confirmed.

A visual and comprehensive overview of cancer worldwide

The new edition of The Cancer Atlas has been launched. This publication is produced by the International Agency for Research on Cancer (IARC), the specialised cancer agency of the World Health Organization, jointly with the American Cancer Society and the Union for International Cancer Control.

Prototype microbial air sampler on show

Cherwell, distributors of the ImpactAir range of microbial air samplers from Pinpoint Scientific, will be displaying the prototype of the new ImpactAir ISO-90 Monitoring Platform on its stand at Pharmig’s Annual Conference (13–14 November, Nottingham Belfry Hotel). ImpactAir is designed for continuous monitoring in high-grade areas, where in-process sampling of viable particles is often critical. The ImpactAir ISO is a modular system designed to integrate into isolators or RABS, using an external controller and remotely located air mover.

Increasing workflow efficiency with HbA1c testing on the DxC 700 AU

Uncontrolled diabetes is associated with serious health problems including cardiovascular disease, neuropathy, nephropathy and retinopathy, and, as such, is a significant burden to the NHS. It is estimated that 8.6% of the adult population in England have diabetes, with this figure expected to rise to 9.7% by 2035.

Review of national cancer screening programmes in England welcomed

Oncimmune, a leading global immunodiagnostics group, has welcomed the publication of the Independent Review of Adult Screening Programmes in England, which makes recommendations on overhauling national cancer screening programmes to aid earlier diagnosis and treatment. Oncimmune's EarlyCDT Lung test, which uses a simple blood sample, can detect lung cancer on average four years or more before standard clinical diagnosis.

University supports company to bring new product to market

A laboratory instrument manufacturer is being helped to bring a new product to international markets thanks to the support of Teesside University. Martel Instruments, based in County Durham, is working with the university to trial a new smart device that connects and records data from instruments in a laboratory.

Innovation and the business of science

Lab Innovations will be opening its doors on Wednesday and Thursday, 30–31 October 2019, to a record number of visitors and exhibitors. With all exhibition space sold out at this award-winning laboratory exhibition showcase, visitors will have access to a huge range of the latest instruments and technologies, as well as learning about future-proofing and sustainable procurement of laboratory products.

Award for advanced digital pathology imaging technology

FFEI is the proud winner of the Institute of Physics (IOP) award for Innovation! The award recognises FFEI for the development of advanced imaging technology in the field of digital pathology.

New laboratory products in the limelight at Lab Innovations

Lab Innovations, the UK’s only trade show dedicated to the laboratory industry, will see a number of new product introductions at Birmingham’s NEC on 30–31 October. Many of the award-winning shows’ exhibitors will be launching or highlighting their very latest laboratory innovations, services and solutions, from general laboratory equipment and informatics, to larger-scale industrial and cleanroom technology.

Advanced technologies and equipment support cutting-edge research

Beckman Coulter Life Sciences is dedicated to developing and providing advanced technologies and equipment for research and discovery to explore new treatment methods.

New research and development facility opened in Cardiff

EKF Diagnostics has opened a new Research and Development (R&D) facility at its Cardiff headquarters. The new Special Projects Laboratory will focus on developing new applications for EKF’s many point-of-care and central laboratory medical products to enable the company to enter new market sectors, as well as providing additional diagnostics sales and regulatory support.

Showcasing sustainability in the laboratory: an innovative approach

Lab Innovations will showcase multiple options to help visitors future-proof their laboratories - from innovative products, to waste reduction (time included!) and sustainability. This focus is reflected in many of Lab Innovations’ key areas, including the Sustainable Laboratory zone, the Royal Society of Chemistry, Insights and Innovation, and Live Lab theatres, as well as on the stands of numerous scientific exhibitors.

G-protein-coupled receptor-specific functional antibody screening

Velabs Therapeutics has announced that its cooperation with Chiome Bioscience, Tokyo, will be deepened, to jointly discover modulatory and functional antibodies for one of Chiome’s G-protein-coupled receptor (GPCR) target genes. The collaboration will capitalise on Velabs’ microfluidics-based technology in the field of functional antibody screening.

Applying liquid chromatography-mass spectrometry to clinical research

Thermo Fisher Scientific and Cedars-Sinai, a leading non-profit academic healthcare organisation, have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows for clinical research applications.

Telomeres: a game-changer in CLL testing

Chronic lymphocytic leukaemia (CLL) is a slowly developing blood cancer in which patients produce mutated versions of white blood cells that build up in the blood, bone marrow and lymph nodes, and crowd out healthy blood cells. It progresses at different rates in different people, and in a third of patients it never progresses at all.